Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer
Background Immunomodulatory therapies targeting the interaction between programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) have become increasingly important in anticancer treatment. Previous research on the subject of this immune response has established an association with tumor...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2020-03-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://jpatholtm.org/upload/pdf/jptm-2019-11-13.pdf |